Non-nucleoside reverse transcriptase inhibitors - PDFSEARCH.IO - Document Search Engine

Non-nucleoside reverse transcriptase inhibitors
Results: 253

#	Item
151	CLINICAL PHARMACOLOGY REVIEW NDA: [removed]SE5 022 & Submission Date(s): December 21, 2007 Brand Name Add to Reading List Source URL: www.fda.gov Language: English Carbamates Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Fixed dose combination Lopinavir Efavirenz Antiretroviral drug Nevirapine Ritonavir Chemistry Organic chemistry Protease inhibitors
152	Microsoft Word - ADAP Formulary WORKING - Revised[removed] Add to Reading List Source URL: www.healthy.arkansas.gov Language: English - Date: 2014-05-28 19:45:31 Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Bristol-Myers Squibb Pharmacology Bupropion Antiretroviral drug Reverse-transcriptase inhibitor Efavirenz Statin Chemistry Organic chemistry Organochlorides
153	Kentucky AIDS Drug Assistance Program Formulary Add to Reading List Source URL: chfs.ky.gov Language: English - Date: 2014-09-09 08:48:52 Gilead Sciences Pharmacology Non-nucleoside reverse transcriptase inhibitors Organofluorides Bristol-Myers Squibb Reverse-transcriptase inhibitor Emtricitabine ATC code J05 Antiretroviral drug Chemistry Organic chemistry Fixed dose combination
154	Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the recommendations that were made by the Drug Managemen Add to Reading List Source URL: www.chfs.ky.gov Language: English - Date: 2014-09-07 09:10:01 Sulfonamides Protease inhibitors Carbamates Non-nucleoside reverse transcriptase inhibitors Ritonavir Delavirdine Efavirenz Dofetilide Itraconazole Chemistry Organic chemistry Pfizer
155	CALIFORNIA CORRECTIONAL HEALTH CARE SERVICES FORMULARY August 2014 Add to Reading List Source URL: www.cphcs.ca.gov Language: English - Date: 2014-09-05 15:47:02 Organofluorides Non-nucleoside reverse transcriptase inhibitors Cyclopropanes Purines Antiretroviral drug Tenofovir Emtricitabine Reverse-transcriptase inhibitor Efavirenz Chemistry Organic chemistry Gilead Sciences
156	Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2013-10-30 10:15:46 Tuberculosis Organofluorides Non-nucleoside reverse transcriptase inhibitors Cyclopropanes Rifamycin antibiotics Efavirenz Nevirapine Tuberculosis treatment Antiretroviral drug Chemistry Organic chemistry Medicine
157	Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection Add to Reading List Source URL: www.cdph.ca.gov Language: English - Date: 2013-01-26 21:50:13 Medicine Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Organofluorides Pandemics Antiretroviral drug HIV AIDS Zidovudine HIV/AIDS Chemistry Organic chemistry
158	CLINICAL REVIEW Application Type NDAs[removed] Add to Reading List Source URL: www.fda.gov Language: English Cyclopropanes Organofluorides Bristol-Myers Squibb Lactams Nevirapine Efavirenz Reverse-transcriptase inhibitor Antiretroviral drug AIDS Clinical Trials Group Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors
159	Isentress (raltegravir) tablets label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-08-06 09:50:44 Gilead Sciences Carbamates Non-nucleoside reverse transcriptase inhibitors Integrase inhibitors Raltegravir Tenofovir Efavirenz Darunavir Antiretroviral drug Chemistry Organic chemistry Organofluorides
160	CLINICAL PHARMACOLOGY REVIEW NDA: [removed]SE5 027 &[removed]SE5 017 Submission Date(s): December 20, 2007 Brand Name Add to Reading List Source URL: www.fda.gov Language: English Non-nucleoside reverse transcriptase inhibitors Amines Drug rehabilitation Lactams Nevirapine Methadone Chemistry Organic chemistry Cyclopropanes

UPDATE